Back to List View Graph View

Atorvastatin

Atorvastatin is a statin-class lipid-lowering drug used primarily to reduce low-density lipoprotein cholesterol and cardiovascular risk.

Where the papers sit

10 papers from the last 6 months study atorvastatin directly · updated from PubMed 16 Nov 2026

  • Statin Effects across Diseases

    Statin benefits and harms remain context-dependent across cardiovascular and neurological settings. Atorvastatin showed limited disease modification in an A53T α-synuclein Parkinson's model, while older-adult analyses address cardiovascular events and disability-free survival. Perioral neuropathic symptoms recur as a rare safety concern. Modeling of statin–ezetimibe combinations points toward mechanistic optimization, but clinical benefit and neurologic effects remain unresolved.

    4 papers · 40%

  • Drug Delivery and Metabolic Effects

    Atorvastatin development is moving toward formulation strategies that improve solubility, release, and tissue delivery. Self-nanoemulsifying hydrogel systems target wound healing, while direct powder extrusion targets immediate-release tablets. Animal metabolic data show context-dependent behavioral and apoptotic effects under cafeteria-diet exposure. The recurring question is whether better delivery translates into reproducible biological benefit.

    3 papers · 30%

  • Ferroptosis in Colorectal Cancer

    Sorafenib–atorvastatin combinations are being developed to trigger apoptosis and ferroptosis together in colorectal cancer. Reactive oxygen species, glutathione depletion, mitochondrial depolarization, and reduced cell viability recur as mechanistic endpoints. Glutamine-tagged polymeric nanoparticles extend this strategy toward co-delivery and tumor-cell targeting. The evidence remains preclinical, leaving selectivity, dosing, and in vivo efficacy open.

    3 papers · 30%

NEW DIRECTION

Atorvastatin emerges as a reproducible cause of perioral small-fibre neuropathic symptoms

The subject of the paper is a patient with perioral neuropathic symptoms during statin treatment. Against the set’s predominant use of atorvastatin as a therapeutic agent or experimental intervention, the report found that dryness, itching, numbness, and tingling around the mouth began after atorvastatin exposure, resolved after discontinuation, and recurred with repeat trials of both atorvastatin and rosuvastatin. This identifies atorvastatin not as a treatment being evaluated but as the suspected cause of a reversible small-fibre neuropathy, adding an adverse neurological role outside the other categories in the set 42637515Aug.

Papers

The 10 papers from the last 6 months that study atorvastatin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Statin Effects across Diseases (4)
  1. Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease. Neurotoxicity research · 9 Sept 2026 PMID 42714756
  2. Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
  3. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults. The New England journal of medicine · 31 Aug 2026 PMID 42670961
  4. An uncommon side effect of statins: perioral neuropathic symptoms. BMJ case reports · 24 Aug 2026 PMID 42637515
Drug Delivery and Metabolic Effects (3)
  1. Direct Powder Extrusion of Atorvastatin 3D-Printed Tablets for Immediate-Release: Solid-State Characterization and Dissolution Performance. AAPS PharmSciTech · 10 Sept 2026 PMID 42717140
  2. Atorvastatin Exerts Context-Dependent Metabolic and Beneficial Effects on Behavior and Apoptotic Signaling in a Cafeteria Diet-Induced Metabolic Dysfunction Model. Neurochemical research · 29 Aug 2026 PMID 42667336
  3. Atorvastatin-loaded frankincense self-nanoemulsifying drug delivery system (SNEDDS) thermoresponsive hydrogel enhances wound healing in an animal model. International journal of pharmaceutics · 1 Aug 2026 PMID 42542257
Ferroptosis in Colorectal Cancer (3)
  1. Glutamine-tagged Sorafenib and Atorvastatin Coloaded Polymeric Nanoparticles for Hybrid Cell Death Induction in Colorectal Cancer: Part I Formulation, Characterization, In-vitro/In-vivo Safety and Efficacy Evaluation. AAPS PharmSciTech · 2 Oct 2026 PMID 42827216
  2. Bioactive biphenyl derivatives from Garcinia nujiangensis and structural revision. Fitoterapia · 15 Jun 2026 PMID 42297079
  3. Exploring Synergistic Potential of Sorafenib and Atorvastatin to Launch Apoptosis and Ferroptosis-driven Mixed Cell Death Mechanism in Colorectal Cancer. AAPS PharmSciTech · 27 May 2026 PMID 42204072

By study type

Clinical trials (1)
  1. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults. The New England journal of medicine · 31 Aug 2026 PMID 42670961
Observational studies and case reports (1)
  1. An uncommon side effect of statins: perioral neuropathic symptoms. BMJ case reports · 24 Aug 2026 PMID 42637515
Human data, design not indexed (2)
  1. Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
  2. Bioactive biphenyl derivatives from Garcinia nujiangensis and structural revision. Fitoterapia · 15 Jun 2026 PMID 42297079
Preclinical: animal, cell and lab studies (6)
  1. Glutamine-tagged Sorafenib and Atorvastatin Coloaded Polymeric Nanoparticles for Hybrid Cell Death Induction in Colorectal Cancer: Part I Formulation, Characterization, In-vitro/In-vivo Safety and Efficacy Evaluation. AAPS PharmSciTech · 2 Oct 2026 PMID 42827216
  2. Direct Powder Extrusion of Atorvastatin 3D-Printed Tablets for Immediate-Release: Solid-State Characterization and Dissolution Performance. AAPS PharmSciTech · 10 Sept 2026 PMID 42717140
  3. Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease. Neurotoxicity research · 9 Sept 2026 PMID 42714756
  4. Atorvastatin Exerts Context-Dependent Metabolic and Beneficial Effects on Behavior and Apoptotic Signaling in a Cafeteria Diet-Induced Metabolic Dysfunction Model. Neurochemical research · 29 Aug 2026 PMID 42667336
  5. Atorvastatin-loaded frankincense self-nanoemulsifying drug delivery system (SNEDDS) thermoresponsive hydrogel enhances wound healing in an animal model. International journal of pharmaceutics · 1 Aug 2026 PMID 42542257
  6. Exploring Synergistic Potential of Sorafenib and Atorvastatin to Launch Apoptosis and Ferroptosis-driven Mixed Cell Death Mechanism in Colorectal Cancer. AAPS PharmSciTech · 27 May 2026 PMID 42204072